|
|
|
Volumn 23, Issue 1 SUPPL. 1, 1996, Pages 53-57
|
|
Paclitaxel-containing combination chemotherapy for metastatic breast cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EDATREXATE;
EPIRUBICIN;
FLUOROURACIL;
IFOSFAMIDE;
MEGESTROL ACETATE;
MITOXANTRONE;
NAVELBINE;
PACLITAXEL;
ADULT;
AGED;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BREAST CANCER;
BREAST METASTASIS;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG TOLERANCE;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
AMINOPTERIN;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
CYCLOPHOSPHAMIDE;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
MITOXANTRONE;
PACLITAXEL;
VINBLASTINE;
|
|
EID: 0029979653
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (13)
|
|
References (0)
|
